Condensed Consolidated Statements of Operations - Unaudited - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Research and development	$ 31,250	$ 32,198	$ 87,887	$ 84,179
General and administrative	17,723	14,419	44,218	43,133
Total operating expenses	48,973	46,617	132,105	127,312
Operating loss	(48,973)	(46,617)	(132,105)	(127,312)
Interest income	5,580	5,541	14,960	16,803
Interest expense	(2)	(2)	(7)	(9)
Net loss before income taxes	(43,395)	(41,078)	(117,152)	(110,518)
Income tax (benefit) expense	(2,342)	913	(2,300)	3,205
Net loss before noncontrolling interest	(41,053)	(41,991)	(114,852)	(113,723)
Net loss attributable to noncontrolling interest	(23,143)	(31,007)	(74,944)	(83,956)
Net loss available to Class A ordinary shareholders	(17,910)	(10,984)	(39,908)	(29,767)
Common Class A [Member]
Operating expenses
Net loss available to Class A ordinary shareholders	$ (17,910)	$ (10,984)	$ (39,908)	$ (29,767)
Weighted average Class A ordinary shares outstanding, Basic	126,173,463	61,592,876	87,818,229	61,565,298
Weighted average Class A ordinary shares outstanding, Diluted	126,173,463	61,592,876	87,818,229	61,565,298
Net loss per share attributable to Class A ordinary shares, Basic	$ (0.14)	$ (0.18)	$ (0.45)	$ (0.48)
Net loss per share attributable to Class A ordinary shares, Diluted	$ (0.14)	$ (0.18)	$ (0.45)	$ (0.48)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.